NGGT Progresses First US Gene Therapy Trials For Rare Conditions

Supported By China Data

US China flags
NGGT leveraging China's large rare disorder patient pools to speed up US trials • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from China

More from Asia